Injectafer (ferric carboxymaltose) is a brand-name injectable solution prescribed for iron deficiency. The cost of the drug, with and without insurance, can depend on several factors, such as whether ...
Injectafer® approved in the U.S. for the treatment of iron deficiency in patients with heart failure
Injectafer ® (ferric carboxymaltose) is now the first and only intravenous (i.v.) iron replacement therapy in the U.S. indicated for improvement in exercise capacity in adult patients with symptomatic ...
Data from the HEART-FID study (NCT03037931) were presented today in a late-breaking research Hot Line session at the European Society of Cardiology Congress 2023. The results were simultaneously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results